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Introduction
In spite of technical refinements, biliary strictures remain 
a key problem in liver transplantation [1]. Two main 
types are recognized: anastomotic and non-anastomotic 
(also called intrahepatic). In anastomotic strictures, good 
results are achieved with surgery or minimally invasive 
therapy [2, 3]. Intrahepatic stenosis usually requires 
retransplantation; however, survival chances are less fa-
vorable [4]. For palliation and bridging to retransplan-
tation, percutaneous and endoscopic interventions are 
used [5]. The treatment options are independent of the 
variable causes, although best results are achieved when 
the hepatic artery stays patent [6, 7]. The extent of the 
strictures may have an important role in therapy plan-
ning, and when more peripheral bile ducts are involved, 
the less successful palliative therapy can be offered. The 
outcomes of the interventions for intrahepatic biliary 
strictures were retrospectively analyzed focusing on the 
extent of the disease. We have raised the question of 
whether we will be able to offer the patients cure, long-
term palliation, or successful bridging. For this, we have 
tried to separate the patients by applying a zonal clas-
sification of the strictures based on the work of Buis et 
al. [8, 9]. According to their work, Zone 1 consists of all 
strictures in the extrahepatic region, including the anas-
tomotic region. Zone 2 strictures involve hepatic bifur-
cation or trifurcation: the lobar ducts. Zone 3 strictures 
are more severe; they are lesions of the segmental ducts. 
Zone 4 strictures are even more peripheral.
Methods
Twenty patients with intrahepatic bile strictures were in-
cluded in this study. Eight patients had Zone 2, eight 
patients had Zone 3, and four patients had Zone 4 le-
sions. Altogether, 34 percutaneous cholangiographies 
(PTC) were performed with the help of ultrasound and 
fluoroscopy guidance. In 33 cases, PTC was converted 
to external or external–internal drainage. In 16 patients, 
58 balloon dilatations were attempted with 5–8 mm bal-
loon catheters. Twenty self-expandable metallic stents 
were implanted percutaneously into 13 patients after 
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Abstract: Introduction: Biliary strictures remain a key problem after liver transplantation. Anastomotic strictures are treated by surgery or 
interventional therapy. Intrahepatic stenosis requires retransplantation. For bridging, percutaneous and endoscopic interventions are used. 
The extent of the strictures may have an important role in therapy planning. Methods: Strictures were divided into four zones (1: extrahepatic, 
not included in this study; 2: hilar; 3: central; 4: peripheral). Twenty patients were treated with balloon dilatation/stent implantation/
retransplantation/supportive care (Zone 1: 0/0/0/0; Zone 2: 8/7/2/0; Zone 3: 7/5/2/1; Zone 4: 1/1/3/1). Results: Mean follow-up time 
was 48 months. In Zone 2, one patient died as a result of recurrent hepatocellular carcinoma (HCC), and seven patients are alive, five after 
stent placements and two after retransplantation. Four patients are alive in Zone 3: all had stent placements and one later retransplantation. 
One patient died after retransplantation, two on the waiting list, and one due to chronic liver failure. One patient is alive in Zone 4 after 
early retransplantation, and three died. Conclusion: Percutaneous therapy is safe and effective in intrahepatic biliary stenosis after liver 
transplantation. It can provide the cure or bridge retransplantation. Based on zonal classification, we recommend the following treatments: 
Zone 4: early retransplantation; Zone 2: minimally invasive therapy; Zone 3: individual decisions.
Keywords: liver transplantation, biliary complication, percutaneous treatment, interventional radiology
clinically unsuccessful balloon dilatation. Nitinol stents 
(diameter: 6−10 mm) were used in 17 and Wallstents 
(diameter: 9−12 mm) in 3; the length of the stents were 
30−40 mm. Seven patients had to undergo retransplan-
tation. Only one major complication was diagnosed after 
percutaneous therapy: a bleeding from the access tract, 
which was embolized with coils.
The choice of treatments was decided individually by 
the liver transplant team (transplant surgeon, anesthesi-
ologist/ICU, hepatologist/endoscopy specialist, inter-
ventional radiologist).
The demographic data and treatment results are pre-
sented in Table I.
Results
As Zone 1 resembles extrahepatic locations, it was not 
included in this study. In Zone 2 (Fig. 1a, b), eight pa-
tients had balloon dilatations followed by stents in seven 
cases and retransplantation in two. In Zone 2, all but 
one patient are alive, five after stent placements and two 
after retransplantation. One patient died because of the 
complications of recurrent metastatic hepatocellular car-
cinoma (HCC) with patent bile ducts. In Zone 3 (Fig. 
2a–d), seven of the eight patients had dilatation followed 
by stent placement in five cases. Retransplantation was 
performed in one case after metallic stent placement and 
in one case after balloon dilatation. Four patients are 
alive in Zone 3; all had stent placements and one was re-
transplanted with stents later. One patient died after stent 
placement as a result of chronic liver failure unrelated to 
the biliary complication. One patient died after repeated 
balloon dilatations, while waiting for retransplantation. 
The cause of death of the third patient was secondary 
biliary cirrhosis. He received only supportive therapy 
and was waiting for retransplantation. The last patient in 
this group had several balloon dilatations and was on the 
waiting list for retransplantation, too. In Zone 4 (Fig. 3), 
one patient had symptomatic treatment only, being on 
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Fig. 1.  (a, b) Percutaneous cholangiography showing Zone 2 
(hilar) stenosis later treated with balloon dilatation and 
stent placement (black arrow shows the stricture, and 
white arrow shows the stent)
Fig. 3. 
 
Zone 4 strictures palliated with double pigtail drainage 
catheters
Fig. 2. 
 
(a–d) Zone 3 lesions treated with external drains fol-
lowed by balloon dilatations and stents (arrows show left 
and right biliary strictures, then the implanted stents)
the waiting list, and three patients had retransplantation. 
One patient is alive in Zone 4 after an early retransplanta-
tion, and three patients died regardless of the treatment. 
The average follow-up time was 48 (15–163) months.
Discussion
Intrahepatic or non-anastomotic biliary strictures are 
one of the serious complications after liver transplanta-
tion. The ultimate therapeutic choice is liver retrans-
plantation [4, 10]. The palliative treatment of symp-
toms may be conservative, consisting management of 
itching, fluid intake, or minimally invasive procedures. 
Surgical resection in the form of  bilio-enteric anasto-
mosis is possible in selected cases, but like endoscopic 
stenting it is mostly unsuccessful [11, 12]. Percutane-
ous interventions, external or external–internal drain-
age, balloon dilatation, and stent implantation can 
usually ease the symptoms and stabilize the patient’s 
condition [13]. The success of treatment may depend 
on the severity of disease. We feel that − as in many 
medical situations − in cases of non-anastomotic post-
transplantation biliary strictures, the real challenge is to 
decide in each case the optimal treatment and the cor-
rect timing. Our retrospective evaluation of our experi-
ence in treating intrahepatic biliary strictures concerns 
outcome depending on the localization and severity 
of the disease. For zonal classification based on the 
percutaneous cholangiography findings [9], however, 
high-quality MRCP (Magnetic Resonance Cholangio-
pancreatograpy) images might provide the necessary 
anatomical information. Zone 1 strictures were ex-
cluded from this analysis, being extrahepatic. Patients 
with Zone 2 and 3 lesions were successfully treated 
percutaneously followed by retransplantation in several 
cases, but patients in Zone 4 faced worse outcome with 
chances of survival only after early retransplantation. 
Many of these patients were treated in the early period 
of the Hungarian Liver Transplantation when retrans-
plantation was rarely performed because of the lack of 
donors. Our experience from the later periods and liter-
ature data suggest that early retransplantation provides 
better results than those presented in this study.
We can assume that percutaneous interventions can 
provide a viable option for bridging to retransplantation, 
or in many cases even to cure the disease.
The available limited data permitted drawing the con-
clusion that percutaneous therapy is safe and effective 
in intrahepatic biliary stenosis after liver transplantation. 
Table I  Demographic data and treatment results
Gender Age (years) Indication of LX Dilatations Stents
ReTx, 
biliary 
related
Exit, biliary 
related
Exit, ReTx 
related
Exit
Female 30 Wilson 1 1 0 0 0 1
Female 41 Acute 3 2 1 0 0 0
Male 55 Adenomatosis 0 0 1 0 1 1
Female 32 Acute 5 1 1 0 1 1
Female 60 Cryptogen 4 1 0 0 0 0
Male 62 Alcoholic 4 2 0 0 0 0
Female 31 Acute 0 0 1 0 0 0
Female 23 Autoimmune 2 1 0 0 0 0
Male 46 PBC 1 1 0 0 0 0
Female 31 HCC/CHCC 3 3 0 0 0 0
Female 39 Autoimmune 6 0 0 1 0 1
Female 11 PSC 3 0 1 0 0 0
Male 53 HCV 4 2 0 0 0 0
Male 59 Alcoholic 3 1 0 0 0 0
Male 50 HCV 0 0 0 1 0 1
Female 23 Autoimmune 6 0 1 0 1 1
Male 31 Acute 3 2 0 0 0 0
Male 50 HCV/HCC 5 2 0 0 0 1
Female 32 Autoimmune 0 0 0 1 0 1
Male 46 Alcoholic 5 1 1 0 0 0
 
(mean) 
40.25
 58 20 7 3 3 8
i n t r a h e p a t i c  b i l i a r y  s t e n o s e s  a n d  l i v e r  t r a n s p l a n t
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Although only a few patients were treated, we empha-
size that zonal classification of strictures is advisable: we 
recommend early retransplantation in Zone 4 strictures, 
minimally invasive therapy in Zone 2, and individual de-
cisions in Zone 3 lesions.
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